c-Abl phosphorylation is robustly increased in brain samples from AD and PD patients as well as in animal models of AD, PD, and synucleinopathies (Ko et al., 2010; Imam et al., 2011; Vargas et al., 2018). Here, ABL1 is linked to Parkinson disease.